RT @colonyrecords: Journal of Clinical Microbiology&Infectious Diseases.“Post marketing experience w $CRMD Neutrolin catheter lock solution…
Journal of Clinical Microbiology&Infectious Diseases.“Post marketing experience w $CRMD Neutrolin catheter lock solution in hemodialysis patients” 0 adverse events.Rate reduction of CRBSI & catheter thrombosis v control...CRMD Ph3 halted approval c
$CRMD continues its move higher on good volume: https://t.co/9y1sETYNrf Recent publication: https://t.co/oZYMdCtcJG
RT @MicrobLog_me_uk: Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in haemodialys…
Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in haemodialysis patients. https://t.co/ivww8grbn7 @ItishaG @renalpages
RT @StuckInStock: Some insight on $CRMD Cormedix R&D Day 2017 https://t.co/OuM2ITEti2. Paper: Neutrolin® catheter lock solution in hemodi…
RT @StuckInStock: Some insight on $CRMD Cormedix R&D Day 2017 https://t.co/OuM2ITEti2. Paper: Neutrolin® catheter lock solution in hemodi…
Some insight on $CRMD Cormedix R&D Day 2017 https://t.co/OuM2ITEti2. Paper: Neutrolin® catheter lock solution in hemodialysis patients https://t.co/hRugwFnQll https://t.co/L0ohl3NjFB